Detalhe da pesquisa
1.
Multiple myeloma-related deregulation of bone marrow-derived CD34(+) hematopoietic stem and progenitor cells.
Blood
; 120(13): 2620-30, 2012 Sep 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-22517906
2.
Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state.
Proc Natl Acad Sci U S A
; 108(19): 7950-5, 2011 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-21498687
3.
Filgrastim biosimilar (EP2006): A review of 15 years' post-approval evidence.
Crit Rev Oncol Hematol
; 196: 104306, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38401695
4.
Patient Experience with the SensoReady® Autoinjector Pen versus a Comparator Device: Results from a Canadian Patient Survey in Rheumatoid Arthritis and Crohn´s Disease.
Patient Prefer Adherence
; 18: 1107-1118, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38854477
5.
Real-World Effectiveness and Safety of SDZ ETN, an Etanercept Biosimilar, in Patients with Rheumatic Diseases: Final Results from Multi-Country COMPACT Study.
Adv Ther
; 41(1): 315-330, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37950790
6.
Treatment with SDZ-ADL, an Adalimumab Biosimilar, in Patients with Rheumatoid Arthritis, Psoriasis, or Psoriatic Arthritis: Results of Patient-Reported Outcome Measures from Two Phase III Studies (ADMYRA and ADACCESS).
BioDrugs
; 35(2): 229-238, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33651341
7.
Switching to Biosimilar SDZ-ADL in Patients with Moderate-to-Severe Active Rheumatoid Arthritis: 48-Week Efficacy, Safety and Immunogenicity Results From the Phase III, Randomized, Double-Blind ADMYRA Study.
BioDrugs
; 34(6): 809-823, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-33119861